Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride reduces DHT more effectively than finasteride.

MK-386 reduces sebum DHT levels.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

The inhibitor DPP can promote hair growth.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

New compounds show promise as nonsteroidal treatments for hair loss.

Male hormones can decrease the ability of immune cells to fight bacteria.

Plant-based treatments might help with hair loss and have fewer side effects than synthetic drugs.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Finasteride safely lowers DHT levels without affecting testosterone.

Testosterone's muscle-building effects do not require its conversion to DHT.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.